Loading Events

« All Events

BioBusiness Insights: Opportunities in Asia – the South Korean Perspective

August 27 @ 9:00 am - 10:00 am AEST

This is Session 3 in the BioBusiness Insights: Opportunities in Regenerative Medicine series. Find out more about about all six sessions, and register for the series at a reduced rate below.

This session will explore opportunities in Asia, specifically from the Japanese perspective. What is the market size, how does their review and approval system work, what are the pathways and challenges in commercialisation of regenerative medicine and how does reimbursement work?

Session 3 Details

Date: Thursday 27 August 2020
Time: 9:00 am – 10:00 am AEST
Format:  This event will be delivered on a virtual platform – you will receive a link to join via a confirmation email following registration.
Single session: Members $35; Non-members $45
Complete series (six sessions): Members $150; Non-members $210
Unsure if your organisation is a member? Check our member directory.
Please note – registration is currently closed for this event, but you can register for the full series here.

Registered? Submit a question for Session 3 ahead of time.


Professor Sora Park, Centre Head, Strategic Centre for Regenerative Medicine (SCRM), South Korea

Series Facilitator

Silvio Tiziani, CEO, CCRM Australia


BioBusiness Insights is delivered in collaboration with the Centre for Commercialization of Regenerative Medicine (CCRM) Australia.

Thanks to our Premier Sponsor for this event series, the State Government of Victoria.

Thanks to our Supporting Sponsor for this event series, Cortellis.

Professor Sora Park, Centre Head, Strategic Centre for Regenerative Medicine (SCRM), South Korea

Dr. Sora Park is a professor of physiology at School of Medicine, Inha University since 1991. She is also a director of Strategic Center for Regenerative Medicine (SCRM, formerly known as GSRAC), funded by the Ministry of Health & Welfare since 2012.
The SCRM is a think tank which provides advice to the Korean government regarding of investment, regulation and R&D strategies in advanced regenerative medicine field. As a director of SCRM, she is also actively engaged in advisory committees on healthcare and advanced regenerative medicine related field in South Korea. She got BA, MD, PhD in Physiology at Yeonsei University, South Korea.

Silvio Tiziani, CEO, CCRM Australia

Silvio Tiziani has played a key role in the establishment of Centre for Commercialisation of Regenerative Medicine (CCRM) Australia with the support of Canada’s CCRM, the Victorian Government and MTPConnect. Silvio is also Director, External Strategy and Planning at the Australian Regenerative Medicine Institute (ARMI). Silvio’s extensive knowledge of the research landscape is well utilised with his networks within the industry, international organisations and state and federal governments.
Silvio has extensive experience in private and public organisations, with a focus on laboratory-based services in government, private organisations, healthcare and research/academia.
In addition to qualifications that include a Bachelor of Science from Swinburne University and a Masters of Business Administration from Monash University, Silvio is also a graduate of the Australian Institute of Company Directors (GAICD). Silvio has extensive experience in financial analysis and budget management, business development, strategic planning and corporate governance along with strong interpersonal skills to lead staff.
Silvio also chairs the Ausbiotech Regenerative Medicine Advisory Group. Comprising leading representatives from industry and academia within the Australian regenerative medicine the Group provides specialist advice to Ausbiotech, Australia’s member-based biotechnology organisation, a peak body that promotes the global growth of Australian biotechnology.


Member - Virtual Ticket$35.00
Member - Series$150.00
Non Member - Virtual Ticket$45.00
Non Member - Series$210.00


August 27
9:00 am - 10:00 am
$35 - $210
Event Category:


BioMelbourne Network
+61 3 9667 8181


News & opinion

Member Directory